Drug intelligence / Profile preview

高热值混合电解质输液I号

Development stage: Preclinical
Lead developer: Jilin Connell Pharmaceutical
Modality: Small Molecules
Administration: Intravenous

Overview

高热值混合电解质输液I号 (High-Calorie Mixed Electrolyte Infusion No. I) is a parenteral nutrition and electrolyte replacement solution developed by Jilin Connell Pharmaceutical. It is formulated to provide both caloric energy, typically through glucose, and a balanced mix of essential electrolytes for patients who cannot maintain adequate nutrition or fluid balance through oral or enteral routes. The product was listed as a research and development project in the 2014 Jilin Province Medical Industry Development Special Fund. It is intended for intravenous administration to support metabolic functions and prevent or treat dehydration and malnutrition in clinical settings.

Other names: High-Calorie Mixed Electrolyte Infusion No. I

Beyond the preview

Go deeper on 高热值混合电解质输液I号.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 高热值混合电解质输液I号.

Explore the full profile